Pre-treatment NLR and Changes in NLR Are Associated With Survival Following the Initiation of Immune Checkpoint Inhibitor Therapy in Patients With Non-small Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Pre-treatment NLR and Changes in NLR Are Associated With Survival Following the Initiation of Immune Checkpoint Inhibitor Therapy in Patients With Non-small Cell Lung Cancer.
Authors: Inomata M; First Department of Internal Medicine, Toyama University Hospital, Toyama, Japan., Matsushiro Y; First Department of Internal Medicine, Toyama University Hospital, Toyama, Japan., Tanabe Y; First Department of Internal Medicine, Toyama University Hospital, Toyama, Japan., Hashizume M; First Department of Internal Medicine, Toyama University Hospital, Toyama, Japan., Azechi K; First Department of Internal Medicine, Toyama University Hospital, Toyama, Japan., Murayama N; First Department of Internal Medicine, Toyama University Hospital, Toyama, Japan., Takata N; First Department of Internal Medicine, Toyama University Hospital, Toyama, Japan., Seto Z; First Department of Internal Medicine, Toyama University Hospital, Toyama, Japan., Tokui K; First Department of Internal Medicine, Toyama University Hospital, Toyama, Japan., Okazawa S; First Department of Internal Medicine, Toyama University Hospital, Toyama, Japan., Imanishi S; First Department of Internal Medicine, Toyama University Hospital, Toyama, Japan., Hayashi R; Department of Medical Oncology and Palliative Medicine, Toyama University Hospital, Toyama, Japan., Kainuma M; Department of Japanese Oriental Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
Source: Cancer diagnosis & prognosis [Cancer Diagn Progn] 2026 Mar 01; Vol. 6 (2), pp. 376-382. Date of Electronic Publication: 2026 Mar 01 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 9918316186306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-7787 (Electronic) Linking ISSN: 27327787 NLM ISO Abbreviation: Cancer Diagn Progn Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2732-7787
DOI:10.21873/cdp.10536